Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity

Hepatology

Volumn 26, Issue 4, 1997, Pages 823-830

  Duan, Rui Dong ^a   Nilsson, Åke ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; 4 NITROPHENYL PHOSPHATE; BILE SALT; CERAMIDE; CHOLIC ACID; GLYCOCHOLIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHORYLCHOLINE; PROTEIN; SEPHADEX; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TAUROCHOLIC ACID;

APOPTOSIS; ARTICLE; BILE; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SUBSTRATE; HEPATOBILIARY DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0030828425     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260403     Document Type: Article

References (33)

1. Kolesnick RN. Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 1991;30:1-38.
2. Hannun YA, Linaedic CM. Sphingolipid breakdown products: antiproliferative and tumor-suppresser lipids. Biochim Biophys Acta 1993; 1154:223-236.
3. Spiegel SN, Merrill Jr AH. Sphingolipid metabolism and cell growth regulation. FASEB J 1996;10:1388-1397.
4. Spence MW. Sphingomyelinase. Adv Lip Res 1993;26:3-23.
5. Chatterjee, S. Neutral sphingomyelinase. Adv Lipid Res 1993;26:25-57.
6. Quintern LE, Schuchman EH, Levran O, Suchi M, Ferlinz K, Reinke H, Sandhoff K, et al. Isolation of cDNA clones encoding human acid sphingomyelinase. Occurrence of alternatively processed transcripts. EMBO J 1989;8:2469-2474.
7. Schuchman EH, Levran O, Pereira LV, Desnick RJ. Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). Genomics 1991;12:197-205.
8. Nilsson Å. The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta 1969;176: 339-347.
9. Duan R-D, Nyberg L, Nilsson Å. Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characterization. Biochim Biophys Acta 1995;1259:49-55.
10. Nyberg L, Duan R-D, Axelsson J, Nilsson Å. Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta 1996; 1300:42-48.
11. Duan R-D, Hertervig E, Nyberg L, Hauge T, Lillienau J, Farooqi A, Nilsson Å. Distribution of alkaline sphingomyelinase activity in human beings and animals: tissue and species differences. Dig Dis Sci 1996; 41:1801-1806.
12. Geelen MJH, Tiburg LBM, Bouma CJ, Beynen AC. Cholesterol consumption alters hepatic sphingomyelin metabolism in rats. J Nutr 1995;125: 2294-2300.
13. Chen H, Born E, Mathur SN, Johlin FC, Field FJ. Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity. Biochem J 1992;286:771-777.
14. Gupta AK, Rudney HL. Plasma membrane sphingomyelinase and the regulation of HMG-CoA reductase activity and cholesterol biosynthesis in cell culture. J Lipid Res 1991;32:125-136.
15. Gottfries A, Nilsson S, Samuelsson B, Schersten T. Phospholipids in human hepatic bile, gall bladder bile, and plasma in cases with acute cholecystitis. Scand J Clin Lab Invest 1968;21:168-176.
16. Gatt S. Magnesium dependent sphingomyelinase. Biochem Biophys Res Commun 1976;68:235-241.
17. Bollag DM, Edelstein SJ. Protein Methods. New York, Wiley-Liss, 1991: 95-156.
18. Previati M, Bertolaso L, Tramarin M, Bertagnolo V, Capitani S. Low nanogram range quantitation of diglycerides and ceramide by high-performance liquid chromatography. Anal Biochem 1996;238:108-114.
19. Pattinson NR, Willis KE. Phospholipase C and diacylglycerol lipase in human gallbladder and hepatic bile. Gastroenterology 1990;99:1798-1806.
20. Barnwell SG, Tuchweber B, Yousef IM. Biliary lipid secretion in the rat during infusion of increasing doses of unconjugated bile acids. Biochim Biophys Acta 1987;922:221-233.
21. Alvaro D, Cantafora A, Attili AF, Corradin SG, De Luca C, Minervini G, Di Biase A, et al. Relationships between bile salts hydrophilicity and phospholipid composition in bile of various animal species. Comp Biochem Physiol 1986;83B:551-554.
22. Hofmann AF. Bile acids. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The Liver, Biology and Pathology. 3rd ed. New York: Raven, 1994:677-718.
23. Jones CS, Shankaran P, Callahan JW. Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography. Biochem J 1981;195:373-382.
24. Yamanaka T, Suzuki K. Acid sphingomyelinase of human brain. Purification to homogeneity. J Neurochem 1982;38:1753-1764.
25. Quintern LE, Weitz G, Nehrkorn H, Tager JM, Schram AW, Sandhoff K. Acid sphingomyelinase from human urine. Purification and characterization. Biochim Biophys Acta 1987;922:323-336.
26. Chatterjee S, Ghosh N. Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies. J Biol Chem 1989;21:12554-12561.
27. Bode Ch J, Zelder O, Neuberger HO. Effect of taurocholate, dehydrocholate and secretin on biliary output of alkaline phosphatase and GOT. Helv Med Acta 1974;37:143-151.
28. Hatoff DE, Hardison WGM. Bile acid-dependent secretion of alkaline phosphatase in rat bile. HEPATOLOGY 1982;2:433-439.
29. Lindman B, Kamenka N, Brun B. Translational motion and association in aqueous sodium cholate solutions. J Colloid Interface Sci 1976;56: 328-336.
30. Hernell O, Bläckberg L. Human milk bile salt-stimulated lipase: functional and molecular aspects. J Pediatr 1994;125:556-861.
31. Juvonen T. Pathogenesis of gallstone. Scand J Gastroenterol 1994;29: 577-582.
32. Gelderblom WCA, Kriek NPJ, Marasas WFO, Thiel PG. Toxicity and carcinogenicity of the fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 1991;12:1247-1251.
33. Hertervig, E, Nilsson Å, Nyberg L, Duan R-D. Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 1997; 79:448-453.